InSights Hub - Page 2 of 37 - Guideline Central

Browse By Focus Browse By Specialty

Showing 10 results in Oncology

Guidelines+ Trials Spotlight - Kisqali HR+HER2 Early Breast Cancer Results (NATALEE)

Kisqali HR+/HER2- Early Breast Cancer Results (NATALEE) – Guidelines+ Trials Spotlight

Published on November 20, 2024

On September 17, 2024, the US Food and Drug Administration (FDA) granted approval for Novartis’s Kisqali® (ribociclib) in combination with an aromatase inhibitor (AI) for the adjuvant treatment of individuals with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) stage II and III early cancer (EBC) at high risk of recurrence, including those with node-negative […]

Focus

Clinical Trials

Specialties

Oncology • Medical Oncology

ASCO’s Thyroid Cancer Guideline is Now Open for Public Comment

Published on November 19, 2024

The American Society of Clinical Oncology (ASCO) has announced that the following guideline, “Systemic Treatment of Thyroid Cancer” is now open for public comment. This latest guideline incorporates new evidence to ensure the most current recommendations are provided. As part of ASCO’s development process, they invite reviews and feedback for a 2-to-3-week period. Interested parties […]

Focus

Guidelines

Specialties

Oncology • Medical Oncology

Guideline Timeline - Stage IV NSCLC Without Driver Alterations

Stage IV NSCLC Without Driver Alterations – Guidelines Timeline

Published on November 14, 2024

In the most recent edition of our Guidelines Timeline Series, we explore the American Society of Clinical Oncology’s (ASCO) guideline on Stage IV Non-Small Cell Lung Cancer without Driver Alterations, which was published on February 28, 2024. This guideline was introduced by ASCO as a living document, that is continuously updated to reflect the latest […]

Focus

Guidelines

Specialties

Oncology

Comparing Prostate Cancer Guidelines – Guidelines Side-By-Side

Published on November 13, 2024

Prostate cancer continues to be the most prevalent non-cutaneous cancer among men in the United States (US), with an estimated 268,490 new cases and 34,500 deaths projected for 2022. Given that the majority of newly diagnosed prostate cancer patients present with localized disease, it is crucial to provide evidence-based guideline statements to guide clinical decision-making […]

Focus

Guidelines

Specialties

Oncology • Medical Oncology • Radiation Oncology • Surgical Oncology • Urology

Guidelines Spotlight Gastropancreatic Neuroendocrine Tumors

Gastroenteropancreatic Neuroendocrine Tumors – Guidelines Spotlight

Published on November 13, 2024

In this edition of our Guideline Spotlight, we will explore the key insights and takeaways from the American Society of Clinical Oncology’s (ASCO) comprehensive guideline, Systemic Therapy for Tumor Control in Metastatic Well-differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs). This guideline offers evidence-based recommendations for the treatment of advanced or metastatic GEP-NETs, a rare group of tumors […]

Focus

Guidelines

Specialties

Gastroenterology • Oncology • Medical Oncology • Radiation Oncology

Guidelines Spotlight Non-Muscle Invasive Bladder Cancer

Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer – Guidelines Spotlight (Bladder Health Awareness Month)

Published on November 7, 2024

In the United States, it is estimated that there will be 83,190 new cases of bladder cancer and 16,840 bladder cancer-related deaths in 2024. Approximately 25% of newly diagnosed patients are found to have muscle-invasive disease, a statistic that has remained relatively unchanged over the past decade according to data from the Surveillance, Epidemiology, and […]

Focus

Guidelines

Specialties

Oncology • Medical Oncology • Radiation Oncology • Surgical Oncology • Urology

Bladder Cancer – Guidelines Rundown (Bladder Health Awareness Month 2024)

Published on November 5, 2024

Welcome to the latest edition of our Guidelines Rundown Series, where we shine a spotlight on the most recent bladder cancer guidelines in recognition of Bladder Health Awareness Month 2024. Multiple medical societies have recently published comprehensive guidelines aimed at assisting healthcare professionals in making informed clinical decisions regarding the diagnosis and treatment of bladder […]

Focus

Guidelines

Specialties

Oncology • Medical Oncology • Radiation Oncology • Surgical Oncology

Guidelines + Journal Rundown Radiation Oncology

Multinational Association of Supportive Care in Cancer (MASCC) – Guidelines International Series

Published on October 25, 2024

In this edition of our Guidelines International Series, we will be examining the guidelines from the Multinational Association of Supportive Care in Cancer (MASCC). MASCC is a global organization committed to advancing the practice, education, and research of supportive care in cancer. MASCC now includes members in over 70 countries around the world. With a […]

Focus

Guidelines

Specialties

Oncology • Medical Oncology • Radiation Oncology • Surgical Oncology

Int'l Guidelines - International Myeloma Working Group (IMWG)

International Myeloma Working Group (IMWG) – Guidelines International Series

Published on October 11, 2024

In the latest edition of the Guidelines International Series, we explore the most recent guidelines published by the prestigious International Myeloma Working Group (IMWG). The IMWG is well known for its series of guidelines and recommendations that focus on the management and treatment of multiple myeloma and related disorders. With numerous research studies and treatment […]

Focus

Guidelines

Specialties

Oncology